Quebec announced over $30 million in funding to support Génome Québec’s ongoing research and innovation efforts, falling short of the organization’s initial expectations. Despite this, President and CEO Josette-Renée Landry expressed gratitude for the support provided by the Ministry of Economy, Innovation, and Energy, acknowledging the challenges posed by the current economic environment.
The reduced funding will lead to adjustments in program frequency and funding allocations, impacting initiatives aimed at integrating genomics into various communities and supporting smaller projects. This limitation may also influence decisions regarding the adoption of advanced technologies within the organization.
Genomics, the study of an organism’s complete genetic material, plays a crucial role in transforming disease understanding, diagnosis, and healthcare delivery. Health Minister Sonia Bélanger highlighted the significant potential of genomics in enabling personalized interventions and improving treatment accuracy, emphasizing the importance of continuous investment in research and technology.
Beyond healthcare, genomics contributes to ecosystem protection by enhancing agricultural resilience, pathogen monitoring, and fostering a competitive bioeconomy. Landry emphasized the strategic significance of genomics as an infrastructure that drives societal and economic advancements.
As Génome Québec commemorates its 25th anniversary, Minister Daniel Bernard reaffirmed the government’s commitment to supporting research and innovation in genomics and the life sciences. The approved funding includes a $28.5 million grant for the 2026-2029 period and an additional allocation of $1.8 million for acquiring advanced technological equipment to meet evolving research demands.
The investment aims to bolster Quebec’s scientific and economic autonomy by preserving expertise, infrastructure, and talent critical for maintaining competitiveness on a global scale.
